‘Dr. Reddy’s Launches Succinylcholine Chloride Injection In US Market

Hyderabad, Nov.13 (Maxim News): Dr. Reddy’s Laboratories announced the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), in US Market.

Dr. Reddy’s Laboratories along with its subsidiaries, announced the launch of Succinylocholine Chloride Injection USP,200mg/ 10ml (20 mg/ML) Multiple-Dose Vials a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration (USFDA).

The Quelicin brand and generic market had U.S. sales of approximately $74.8 million MAT for the most recent twelve months ending in September 2020 according to IQVIA Health.

Dr. Reddy’s Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), is available in multi-dose vials. (Maxim News)

Now you can get latest stories from Indtoday on Telegram everyday. Click the link to subscribe.  Click to follow Indtoday Facebook page and Twitter and on Instagram